Amelunxen, E.; Wülfrath, H.S.; von Samson-Himmelstjerna, F.A.; Niehus, C.B.; Kolbrink, B.; Schulte, K.; Schmitt, R.; Sievers, L.K.
Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults Undergoing Peritoneal Dialysis: A Propensity-Matched Real-World Data Analysis. J. Clin. Med. 2025, 14, 8815.
https://doi.org/10.3390/jcm14248815
AMA Style
Amelunxen E, Wülfrath HS, von Samson-Himmelstjerna FA, Niehus CB, Kolbrink B, Schulte K, Schmitt R, Sievers LK.
Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults Undergoing Peritoneal Dialysis: A Propensity-Matched Real-World Data Analysis. Journal of Clinical Medicine. 2025; 14(24):8815.
https://doi.org/10.3390/jcm14248815
Chicago/Turabian Style
Amelunxen, Eric, Hauke S. Wülfrath, Friedrich A. von Samson-Himmelstjerna, Christoph B. Niehus, Benedikt Kolbrink, Kevin Schulte, Roland Schmitt, and Laura Katharina Sievers.
2025. "Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults Undergoing Peritoneal Dialysis: A Propensity-Matched Real-World Data Analysis" Journal of Clinical Medicine 14, no. 24: 8815.
https://doi.org/10.3390/jcm14248815
APA Style
Amelunxen, E., Wülfrath, H. S., von Samson-Himmelstjerna, F. A., Niehus, C. B., Kolbrink, B., Schulte, K., Schmitt, R., & Sievers, L. K.
(2025). Sodium-Glucose Cotransporter 2 Inhibitor Use in Adults Undergoing Peritoneal Dialysis: A Propensity-Matched Real-World Data Analysis. Journal of Clinical Medicine, 14(24), 8815.
https://doi.org/10.3390/jcm14248815